Juliana Peçanha Antonio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Juliana Peçanha Antonio has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Ana Carolina Peçanha Antonio
Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
2 shared publications - Jussara Carnevale de Almeida
Post-Graduate Program in Food, Nutrition and Health, Universidade Federal do Rio Grande do Sul
2 shared publications - Adriano José Pereira
Hospital Israelita Albert Einstein - São Paulo (SP), Brazil
1 shared publication - Alexandre Prehn Zavascki
Infectious Diseases and Infection Control Service, Hospital Moinhos de Vento, Porto Alegre, Brazil
1 shared publication - Ana Maria Keller Jochims
Hospital de Clínicas de Porto Alegre, Brasil
1 shared publication - Andre Celestino Kalil
Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center , Omaha, NE
1 shared publication
Latest Publications
- Open Access
- 29 July 2025
- Published by Universidade do Estado do Rio de Janeiro in DEMETRA: Alimentação, Nutrição & Saúde
- Vol. 20, e74941
A diet protocol for patients on non-invasive ventilation admitted to a healthcare unit in a tertiary referral center in southern Brazil
Introduction: The COVID-19 pandemic posed unprecedented challenges and threats to patients and healthcare systems worldwide. The high risk of malnutrition highlighted the importance of early nutrition intervention. Objective: To develop a personalized dietary protocol for patients requiring non-invasive ventilation (NIV). Methods: This was a descriptive observational study included adult NIV patients admitted to a tertiary referral center in southern Brazil between March and August 2021. Patients received a dietary protocol consisting of a fractionated, liquidized and pureed diet, supplemented with isolated whey protein. The protocol provided 2,000 kcal/day and 90 g of protein/day. Food intake was continuous monitored using a visual intake scale. The study was approved by the hospital’s ethics committee. Results: A total of 176 patients were evaluated, most male (57%), with a mean age of 56 ± 15 years. The median onset of respiratory symptoms was 9 days. According to the NRS-2002, 83% of the patients were classified as being at risk of malnutrition. Upon admission, 86% required oxygen support, and 94% were exclusively fedorally, with 50% receiving the prescribed diet protocol. Patients on NIV consumed more than half of the prescribed diet and were able to progress to a regular consistency diet by discharge. Conclusion: A fractionated, modified-consistency diet that is easy to chew appears to be a feasible alternative to nasoenteric tube feeding for patients on NIV. In this context, nutritional therapy should be considered a fundamental component of care for these patients in all healthcare settings.
- 29 July 2025
- Published by Universidade do Estado do Rio de Janeiro in DEMETRA: Alimentação, Nutrição & Saúde
- Vol. 20, e74941
Open AccessA diet protocol for patients on non-invasive ventilation admitted to a healthcare unit in a tertiary referral center in southern Brazil
Introduction: The COVID-19 pandemic posed unprecedented challenges and threats to patients and healthcare systems worldwide. The high risk of malnutrition highlighted the importance of early nutrition intervention. Objective: To develop a personalized dietary protocol for patients requiring non-invasive ventilation (NIV). Methods: This was a descriptive observational study included adult NIV patients admitted to a tertiary referral center in southern Brazil between March and August 2021. Patients received a dietary protocol consisting of a fractionated, liquidized and pureed diet, supplemented with isolated whey protein. The protocol provided 2,000 kcal/day and 90 g of protein/day. Food intake was continuous monitored using a visual intake scale. The study was approved by the hospital’s ethics committee. Results: A total of 176 patients were evaluated, most male (57%), with a mean age of 56 ± 15 years. The median onset of respiratory symptoms was 9 days. According to the NRS-2002, 83% of the patients were classified as being at risk of malnutrition. Upon admission, 86% required oxygen support, and 94% were exclusively fedorally, with 50% receiving the prescribed diet protocol. Patients on NIV consumed more than half of the prescribed diet and were able to progress to a regular consistency diet by discharge. Conclusion: A fractionated, modified-consistency diet that is easy to chew appears to be a feasible alternative to nasoenteric tube feeding for patients on NIV. In this context, nutritional therapy should be considered a fundamental component of care for these patients in all healthcare settings.
- Open Access
- 18 December 2024
- Published by Springer Nature in Critical Care
- Vol. 28 (1) , 1-12
Seven versus 14 days of antimicrobial therapy for severe multidrug-resistant Gram-negative bacterial infections in intensive care unit patients (OPTIMISE): a randomised, open-label, non-inferiority clinical trial
Shorter courses of antimicrobial therapy have been shown to be non-inferior to longer durations for the management of several infections. However, data on critically ill patients with severe infections by multidrug-resistant Gram-negative bacteria (MDR-GNB) are scarce. In the duratiOn of theraPy in severe infecTIons by MultIdrug-reSistant gram-nEgative bacteria (OPTIMISE) trial, we assessed the non-inferiority of 7-day versus 14-day antimicrobial therapy for patients with intensive care unit (ICU)-acquired severe infections by MDR-GNB. This was a randomised multicenter, open-label, parallel controlled, non-inferiority trial. Adult patients with severe infections by MDR-GNB initiated ≥ 48 h of ICU admission were eligible if they were hemodynamically stable and without fever > 48 h on the 7th day of appropriate antimicrobial therapy. Patients were 1:1 randomised to discontinue antimicrobial therapy on the 7th (± 1) day or to continue for a total of 14 (± 1) days. The primary outcome was clinical failure, defined as death or relapse of infection within 28 days of randomisation. An upper edge of the two-tailed 95% confidence interval (CI) of the delta between the clinical failure rate in the 7- and the 14-day lower than 10% in both intention-to-treat (ITT) and per protocol (PP) analyses was set as the non-inferiority criteria. A total of 106 patients composed the ITT population: 59 and 47 allocated to 7- and 14-day groups, respectively. The PP population included 75 patients: 47 and 28 in the 7- and 14-day groups, respectively. Clinical failure occurred in 42.4% and 44.7% of the ITT population in 7- and 14-day groups, respectively, (risk difference (RD) − 2.3, 95%CI − 21.3 to 16.7), and in 46.8% and 50.0% of the PP population in 7- and 14-day groups, respectively (RD − 3.2, 95%CI − 26.6 to 20.2). Most infections were of the respiratory tract (73/68.9%) and caused by carbapenem-resistant Enterobacterales (42/39.6%). The study was interrupted before reaching planned sample size due to low recruitment rate. The OPTIMISE trial could not determine the non-inferiority of 7-day compared to 14-day therapy for severe infections caused by MDR-GNB due to early termination related to the low recruitment rate. Trial registration: NCT05210387 on January 13, 2022.
- 18 December 2024
- Published by Springer Nature in Critical Care
- Vol. 28 (1) , 1-12
Open AccessSeven versus 14 days of antimicrobial therapy for severe multidrug-resistant Gram-negative bacterial infections in intensive care unit patients (OPTIMISE): a randomised, open-label, non-inferiority clinical trial
Shorter courses of antimicrobial therapy have been shown to be non-inferior to longer durations for the management of several infections. However, data on critically ill patients with severe infections by multidrug-resistant Gram-negative bacteria (MDR-GNB) are scarce. In the duratiOn of theraPy in severe infecTIons by MultIdrug-reSistant gram-nEgative bacteria (OPTIMISE) trial, we assessed the non-inferiority of 7-day versus 14-day antimicrobial therapy for patients with intensive care unit (ICU)-acquired severe infections by MDR-GNB. This was a randomised multicenter, open-label, parallel controlled, non-inferiority trial. Adult patients with severe infections by MDR-GNB initiated ≥ 48 h of ICU admission were eligible if they were hemodynamically stable and without fever > 48 h on the 7th day of appropriate antimicrobial therapy. Patients were 1:1 randomised to discontinue antimicrobial therapy on the 7th (± 1) day or to continue for a total of 14 (± 1) days. The primary outcome was clinical failure, defined as death or relapse of infection within 28 days of randomisation. An upper edge of the two-tailed 95% confidence interval (CI) of the delta between the clinical failure rate in the 7- and the 14-day lower than 10% in both intention-to-treat (ITT) and per protocol (PP) analyses was set as the non-inferiority criteria. A total of 106 patients composed the ITT population: 59 and 47 allocated to 7- and 14-day groups, respectively. The PP population included 75 patients: 47 and 28 in the 7- and 14-day groups, respectively. Clinical failure occurred in 42.4% and 44.7% of the ITT population in 7- and 14-day groups, respectively, (risk difference (RD) − 2.3, 95%CI − 21.3 to 16.7), and in 46.8% and 50.0% of the PP population in 7- and 14-day groups, respectively (RD − 3.2, 95%CI − 26.6 to 20.2). Most infections were of the respiratory tract (73/68.9%) and caused by carbapenem-resistant Enterobacterales (42/39.6%). The study was interrupted before reaching planned sample size due to low recruitment rate. The OPTIMISE trial could not determine the non-inferiority of 7-day compared to 14-day therapy for severe infections caused by MDR-GNB due to early termination related to the low recruitment rate. Trial registration: NCT05210387 on January 13, 2022.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (6) , e20230208
Palliative extubation experience in a community hospital in southern Brazil
Sustaining invasive mechanical ventilation may inappropriately prolong the dying process and perpetuate states worse than death in end-of-life care. Even though withdrawing the ventilator in this circumstance is a well-established practice worldwide1 1 Efstathiou N, Vanderspank-Wright B, Vandyk A, Al-Janabi M, Daham Z, Sarti A, et al. Terminal withdrawal of mechanical ventilation in adult intensive care units: a systematic review and narrative synthesis of perceptions, experiences and practices. Palliat Med. 2020;34(9):1140-64. https://doi.org/10.1177/0269216320935002 https://doi.org/10.1177/0269216320935002... , Brazilian physicians are far more likely to withhold than withdraw life-sustaining treatments2 2 Yaguchi A, Truog RD, Curtis JR, Luce JM, Levy MM, Mélot C, et al. International differences in end-of-life attitudes in the intensive care unit: results of a survey. Arch Intern Med. 2005;165(17):1970-5. https://doi.org/10.1001/archinte.165.17.1970 https://doi.org/10.1001/archinte.165.17.... –5 5 Furtado RA, Tonial CT, Costa CAD, Andrades GRH, Crestani F, Bruno F, et al. End-of-life practices in patients admitted to pediatric intensive care units in Brazil: a retrospective study. J Pediatr (Rio J). 2021;97(5):525-30. https://doi.org/10.1016/j.jped.2020.10.017 https://doi.org/10.1016/j.jped.2020.10.0... .
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (6) , e20230208
Open AccessPalliative extubation experience in a community hospital in southern Brazil
Sustaining invasive mechanical ventilation may inappropriately prolong the dying process and perpetuate states worse than death in end-of-life care. Even though withdrawing the ventilator in this circumstance is a well-established practice worldwide1 1 Efstathiou N, Vanderspank-Wright B, Vandyk A, Al-Janabi M, Daham Z, Sarti A, et al. Terminal withdrawal of mechanical ventilation in adult intensive care units: a systematic review and narrative synthesis of perceptions, experiences and practices. Palliat Med. 2020;34(9):1140-64. https://doi.org/10.1177/0269216320935002 https://doi.org/10.1177/0269216320935002... , Brazilian physicians are far more likely to withhold than withdraw life-sustaining treatments2 2 Yaguchi A, Truog RD, Curtis JR, Luce JM, Levy MM, Mélot C, et al. International differences in end-of-life attitudes in the intensive care unit: results of a survey. Arch Intern Med. 2005;165(17):1970-5. https://doi.org/10.1001/archinte.165.17.1970 https://doi.org/10.1001/archinte.165.17.... –5 5 Furtado RA, Tonial CT, Costa CAD, Andrades GRH, Crestani F, Bruno F, et al. End-of-life practices in patients admitted to pediatric intensive care units in Brazil: a retrospective study. J Pediatr (Rio J). 2021;97(5):525-30. https://doi.org/10.1016/j.jped.2020.10.017 https://doi.org/10.1016/j.jped.2020.10.0... .
- 18 October 2022
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 33 (2) , 261-268
Association of Eating Patterns and Diabetic Kidney Disease in Type 2 Diabetes: A Cross-Sectional Study
- 18 October 2022
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 33 (2) , 261-268
Association of Eating Patterns and Diabetic Kidney Disease in Type 2 Diabetes: A Cross-Sectional Study
- Open Access
- 23 December 2014
- Published by Springer Nature in Nutrition Journal
- Vol. 13 (1) , 1-7
Adiposity markers and risk of coronary heart disease in patients with type 2 diabetes mellitus
This cross-sectional study aimed to evaluating the association between body adiposity markers and high-risk of coronary heart disease (CHD) in patients with type 2 diabetes. Recent adiposity markers [waist-to-height ratio, conicity index (C-index) and body adiposity index] and traditional markers [BMI, waist circumference and waist-to-hip ratio (WHR)] were measured. The 10-year risk of fatal CHD was estimated according to UKPDS risk engine scores. Patients were divided into high (CHD risk ≥20%; n = 99) or low-moderate (CHD risk 20% (OR = 1.69; 95% CI 1.03-2.78; P = 0.039) after adjusting for confounders (sedentary lifestyle, diabetic nephropathy, serum creatinine, and diabetes duration). The association between WHR and CHD risk did not hold in this sample. The C-index was the body adiposity marker best associated with high risk of fatal CHD in these patients with type 2 diabetes.
- 23 December 2014
- Published by Springer Nature in Nutrition Journal
- Vol. 13 (1) , 1-7
Open AccessAdiposity markers and risk of coronary heart disease in patients with type 2 diabetes mellitus
This cross-sectional study aimed to evaluating the association between body adiposity markers and high-risk of coronary heart disease (CHD) in patients with type 2 diabetes. Recent adiposity markers [waist-to-height ratio, conicity index (C-index) and body adiposity index] and traditional markers [BMI, waist circumference and waist-to-hip ratio (WHR)] were measured. The 10-year risk of fatal CHD was estimated according to UKPDS risk engine scores. Patients were divided into high (CHD risk ≥20%; n = 99) or low-moderate (CHD risk 20% (OR = 1.69; 95% CI 1.03-2.78; P = 0.039) after adjusting for confounders (sedentary lifestyle, diabetic nephropathy, serum creatinine, and diabetes duration). The association between WHR and CHD risk did not hold in this sample. The C-index was the body adiposity marker best associated with high risk of fatal CHD in these patients with type 2 diabetes.